- Home
- NUS vs TALK Comparison
NUS vs TALK Comparison
Compare NUS & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- TALK
- Stock Information
- Founded
- NUS 1984
- TALK 2012
- Country
- NUS United States
- TALK United States
- Employees
- NUS N/A
- TALK N/A
- Industry
- NUS Other Pharmaceuticals
- TALK Medical/Nursing Services
- Sector
- NUS Health Care
- TALK Health Care
- Exchange
- NUS Nasdaq
- TALK Nasdaq
- Market Cap
- NUS 440.8M
- TALK 443.4M
- IPO Year
- NUS 1996
- TALK N/A
- Fundamental
- Price
- NUS $8.20
- TALK $2.31
- Analyst Decision
- NUS Hold
- TALK Buy
- Analyst Count
- NUS 2
- TALK 6
- Target Price
- NUS $6.88
- TALK $4.50
- AVG Volume (30 Days)
- NUS 447.2K
- TALK 1.4M
- Earning Date
- NUS 08-07-2025
- TALK 08-05-2025
- Dividend Yield
- NUS 2.86%
- TALK N/A
- EPS Growth
- NUS N/A
- TALK N/A
- EPS
- NUS N/A
- TALK 0.02
- Revenue
- NUS $1,679,268,000.00
- TALK $194,359,000.00
- Revenue This Year
- NUS N/A
- TALK $21.98
- Revenue Next Year
- NUS N/A
- TALK $20.60
- P/E Ratio
- NUS N/A
- TALK $133.04
- Revenue Growth
- NUS N/A
- TALK 19.88
- 52 Week Low
- NUS $5.32
- TALK $1.60
- 52 Week High
- NUS $11.41
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- NUS 44.45
- TALK 31.99
- Support Level
- NUS $8.63
- TALK $2.50
- Resistance Level
- NUS $8.97
- TALK $2.61
- Average True Range (ATR)
- NUS 0.38
- TALK 0.11
- MACD
- NUS -0.11
- TALK -0.01
- Stochastic Oscillator
- NUS 8.19
- TALK 2.86
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.